Stockscreener 앱 받기
15.10
4.93%
0.71
시장 영업 전:
15.09
-0.010
-0.07%
Zymeworks Inc. 주식(ZYME)의 최신 뉴스
Implied Analyst Target Price of $70.96 for iShares Morningstar Small-Cap ETF (ISCB) Suggests 16% Gain Potential. - AInvest
Zymeworks to Engage in Key Investor Conferences - TipRanks
Zymeworks to Participate in Upcoming Investor Conferences. - AInvest
Zymeworks' Strategic Momentum in 2025: A High-Conviction Biotech Play in the ADC and Bispecific Antibody Space - AInvest
Zymeworks Inc. to Participate in Multiple Upcoming Investor Conferences in September 2025 - Quiver Quantitative
Zymeworks to Present at Several Upcoming Investor Conferences - AInvest
Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire
Clinical-Stage Biotech Zymeworks Lines Up 4 Major Wall Street Healthcare Conference Presentations in September - Stock Titan
RSI Crosses Above 30 for Zymeworks Inc. — Reversal in SightPortfolio Value Report & Weekly Watchlist of Top Performers - 선데이타임즈
Short Interest Drops in Zymeworks Inc. After RallyMarket Growth Review & Fast Moving Market Watchlists - newsimpact.co.kr
Is Zymeworks Inc. stock forming a triangle patternJuly 2025 Action & AI Forecast Swing Trade Picks - sundaytimes.kr
What is the cash position of Zymeworks Inc.2025 Winners & Losers & Weekly Momentum Stock Picks - mustnews.co.kr
Zymeworks Inc. Revenue Forecasts Upgraded by 44%: Analysts See Substantial Growth Ahead - AInvest
Growth Investors: Industry Analysts Just Upgraded Their Zymeworks Inc. (NASDAQ:ZYME) Revenue Forecasts By 44% - Yahoo Finance
Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 - Caledon Enterprise
Zymeworks signals expanded royalty streams and milestone-driven cash infusions through new approvals and pipeline progression - MSN
Will Breakout in Zymeworks Inc. Sustain Through Next WeekJuly 2025 Drop Watch & Free Technical Pattern Based Buy Signals - beatles.ru
Screener Results Flag Zymeworks Inc. as OversoldTrade Risk Assessment & Free Reliable Trade Execution Plans - thegnnews.com
Short Term Charts Align With Long Term Uptrend in Zymeworks Inc.July 2025 Review & Long-Term Capital Growth Strategies - sundaytimes.kr
Zymeworks Inc. Added to Custom Quant Screener Today2025 Buyback Activity & Free Fast Entry Momentum Trade Alerts - thegnnews.com
Zymeworks (ZYME) Is Up 12.3% After Board Shakeup, Insider Investment, and Return to Profitability – Has The Bull Case Changed? - simplywall.st
Zymeworks (NASDAQ:ZYME) Issues Earnings Results - MarketBeat
Zymeworks (ZYME) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
Zymeworks Inc. (NASDAQ:ZYME) Q2 2025 Earnings Call Transcript - Insider Monkey
Zymeworks Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - 富途牛牛
Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry - Ariva
Zymeworks Strengthens Leadership with New Board Appointments - TipRanks
Zymeworks Expands Board with Financial Veterans Greg Ciongoli and Robert E. Landry - The Indian Awaaz
Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry | ZYME Stock News - GuruFocus
Zymeworks Inc. Appoints Greg Ciongoli and Robert E. Landry to Board of Directors - Quiver Quantitative
Zymeworks appoints two new directors to strengthen board By Investing.com - Investing.com Canada
Zymeworks appoints two new directors to strengthen board - Investing.com India
Zymeworks Strengthens Board with Healthcare Veterans as Key Trial Results Near - Stock Titan
Will breakout in Zymeworks Inc. lead to full recoveryFree Breakout Entry Signal Confirmation Tool - Newser
Has Zymeworks Inc. formed a bullish divergenceLow Risk Stock Selection Strategy Guide - Newser
Zymeworks Inc. stock trendline breakdownFree Scalable Portfolio Growth Suggestions - Newser
Zymeworks Inc. stock outlook for YEARWealth Accumulation Outlook for Safe Investors - Newser
Zymeworks Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates - simplywall.st
Earnings Beat: Zymeworks Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Is Zymeworks Inc. forming a breakout patternDouble Capital Strategy Picks - thegnnews.com
Can Zymeworks Inc. hit a new high this monthFree Proven Entry Plan With Low Risk Trade - Newser
Zymeworks Inc. (NYSE:ZYME) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Applying sector rotation models to Zymeworks Inc.Technical Reversal Setup with Risk Limits - Newser
What does recent volatility data suggest for Zymeworks Inc.Stock Price Prediction Using AI Tools - Newser
Why Zymeworks Inc. stock attracts strong analyst attentionFree High Yield Stocks With Buy Confirmation - Newser
Is Zymeworks Inc. affected by consumer sentimentStock Picks with 300% Gain - sisaissue.com
Zymeworks Q2 2025 Earnings Call: Capitalizing on Platform-Driven Innovation and Strategic Execution - AInvest
Zurcher Kantonalbank Zurich Cantonalbank Purchases 4,920 Shares of Zymeworks Inc. (NYSE:ZYME) - Defense World
Zymeworks (NASDAQ:ZYME) Lowered to “Hold” Rating by Wall Street Zen - Defense World
Zymeworks Reports Strong Q2 2025 Financial Performance - The Globe and Mail
Zymeworks Reports Q2 Results and FDA Clearance - The Globe and Mail
Transcript : Zymeworks Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Zymeworks Inc. 2025 Q2 Earnings and Strategic Progress: A Catalyst for Oncology Innovation and Shareholder Value - AInvest
Zymeworks: Unleashing Long-Term Value Through Royalty-Driven Growth and Strategic Pipeline Execution - AInvest
Zymeworks Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:ZYME) - Seeking Alpha
Earnings call transcript: Zymeworks sees revenue surge in Q2 2025 By Investing.com - Investing.com Nigeria
Earnings call transcript: Zymeworks sees revenue surge in Q2 2025 - Investing.com
0.94%
1.72%
자본화:
|
볼륨(24시간):